Posts | Health Technology Assessment Division

Evidence brief for 22 July 2022 to 29 July 2022

Posted on August 1, 2022

Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 22 July 2022 to 29 July 2022

Preliminary Recommendation for the Inclusion of Insulin Glargine and Insulin Detemir for Type 1 and Type 2 Diabetes Mellitus in the PNF

Posted on July 26, 2022

Evidence brief for 15 to 21 July 2022

Posted on July 25, 2022

For the period of 15 July 2022 to 21 July 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 15 to 21 July 2022

Evidence brief for 08 to 14 July 2022

Posted on July 18, 2022

For the period of 08 to 14 July 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 08 to 14 July 2022

Evidence brief for 01 to 07 July 2022

Posted on July 12, 2022

For the period of 01 July 2021 to 07 July 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 01 to 07 July 2022